questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Processus néoplasiques
Métastase tumorale
Essaimage tumoral
Essaimage tumoral : Questions médicales fréquentes
Diagnostic
5
Imagerie par résonance magnétique
Tomodensitométrie
Marqueurs tumoraux
Néoplasmes
Analyse sanguine
Marqueurs tumoraux
Symptômes
5
Fonction organique
Néoplasmes
Traitements
5
Chimiothérapie
Radiothérapie
Chimiothérapie
Néoplasmes
Thérapies ciblées
Néoplasmes
Complications
5
Qualité de vie
Néoplasmes
Problèmes respiratoires
Néoplasmes
Facteurs de risque
5
Facteurs de risque
Néoplasmes
Mode de vie
Facteurs de risque
Infections
Facteurs de risque
Substances toxiques
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Essaimage tumoral : Questions médicales les plus fréquentes",
"headline": "Essaimage tumoral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Essaimage tumoral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-01",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Essaimage tumoral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métastase tumorale",
"url": "https://questionsmedicales.fr/mesh/D009362",
"about": {
"@type": "MedicalCondition",
"name": "Métastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Essaimage tumoral",
"alternateName": "Neoplasm Seeding",
"code": {
"@type": "MedicalCode",
"code": "D009366",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Naseema Gangat",
"url": "https://questionsmedicales.fr/author/Naseema%20Gangat",
"affiliation": {
"@type": "Organization",
"name": "Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Umberto Gianelli",
"url": "https://questionsmedicales.fr/author/Umberto%20Gianelli",
"affiliation": {
"@type": "Organization",
"name": "University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy."
}
},
{
"@type": "Person",
"name": "Jürgen Thiele",
"url": "https://questionsmedicales.fr/author/J%C3%BCrgen%20Thiele",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University of Cologne, Cologne, Germany."
}
},
{
"@type": "Person",
"name": "Attilio Orazi",
"url": "https://questionsmedicales.fr/author/Attilio%20Orazi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA."
}
},
{
"@type": "Person",
"name": "Alessandro M Vannucchi",
"url": "https://questionsmedicales.fr/author/Alessandro%20M%20Vannucchi",
"affiliation": {
"@type": "Organization",
"name": "CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.",
"datePublished": "2022-11-19",
"url": "https://questionsmedicales.fr/article/36401651",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-022-05903-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report.",
"datePublished": "2023-10-24",
"url": "https://questionsmedicales.fr/article/37875852",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12890-023-02712-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gastric intramural metastasis caused by needle tract seeding after preoperative fine needle aspiration for pancreatic body cancer subsequently resected by total pancreatectomy: a case report and literature review.",
"datePublished": "2023-02-13",
"url": "https://questionsmedicales.fr/article/36782222",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-023-02914-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "A typical anterior retinoblastoma: diagnosis by aqueous humor cell-free DNA analysis.",
"datePublished": "2022-11-03",
"url": "https://questionsmedicales.fr/article/36326029",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2022.2141800"
}
},
{
"@type": "ScholarlyArticle",
"name": "Co-occurrence of myeloid neoplasm and plasma cell neoplasm.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35935173",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4322/acr.2021.393"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
},
{
"@type": "ListItem",
"position": 5,
"name": "Métastase tumorale",
"item": "https://questionsmedicales.fr/mesh/D009362"
},
{
"@type": "ListItem",
"position": 6,
"name": "Essaimage tumoral",
"item": "https://questionsmedicales.fr/mesh/D009366"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Essaimage tumoral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Essaimage tumoral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Essaimage tumoral",
"description": "Comment diagnostiquer un essaimage tumoral ?\nQuels examens sont utilisés pour détecter l'essaimage ?\nLes marqueurs tumoraux aident-ils au diagnostic ?\nQuelle est l'importance de la biopsie dans le diagnostic ?\nPeut-on détecter l'essaimage par des analyses sanguines ?",
"url": "https://questionsmedicales.fr/mesh/D009366#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Essaimage tumoral",
"description": "Quels sont les symptômes d'un essaimage tumoral ?\nL'essaimage peut-il causer des douleurs ?\nComment l'essaimage affecte-t-il la fonction organique ?\nY a-t-il des symptômes généraux associés ?\nLes symptômes varient-ils selon le type de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009366#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Essaimage tumoral",
"description": "Peut-on prévenir l'essaimage tumoral ?\nQuels modes de vie aident à réduire le risque ?\nLe tabagisme influence-t-il l'essaimage ?\nLes vaccinations peuvent-elles aider ?\nLe dépistage précoce est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D009366#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Essaimage tumoral",
"description": "Quels traitements sont disponibles pour l'essaimage tumoral ?\nLa chirurgie est-elle efficace contre l'essaimage ?\nComment la chimiothérapie aide-t-elle ?\nLa radiothérapie est-elle utilisée pour l'essaimage ?\nY a-t-il des traitements ciblés pour l'essaimage ?",
"url": "https://questionsmedicales.fr/mesh/D009366#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Essaimage tumoral",
"description": "Quelles complications peuvent survenir avec l'essaimage ?\nL'essaimage peut-il entraîner des métastases multiples ?\nComment l'essaimage affecte-t-il la qualité de vie ?\nY a-t-il un risque accru d'infections ?\nL'essaimage peut-il causer des problèmes respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D009366#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Essaimage tumoral",
"description": "Quels sont les principaux facteurs de risque d'essaimage ?\nL'hérédité joue-t-elle un rôle dans l'essaimage ?\nLe mode de vie influence-t-il le risque d'essaimage ?\nLes infections chroniques augmentent-elles le risque ?\nL'exposition à des substances toxiques est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D009366#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un essaimage tumoral ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie médicale et les biopsies des lésions suspectes."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour détecter l'essaimage ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les examens d'imagerie comme l'IRM, le scanner et la scintigraphie sont courants."
}
},
{
"@type": "Question",
"name": "Les marqueurs tumoraux aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs tumoraux peuvent indiquer un essaimage tumoral."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la biopsie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet de confirmer la présence de cellules cancéreuses dans les métastases."
}
},
{
"@type": "Question",
"name": "Peut-on détecter l'essaimage par des analyses sanguines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines analyses peuvent révéler des marqueurs, mais l'imagerie est plus précise."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un essaimage tumoral ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon l'organe touché, incluant douleur, fatigue et perte de poids."
}
},
{
"@type": "Question",
"name": "L'essaimage peut-il causer des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'essaimage dans certains organes peut provoquer des douleurs localisées."
}
},
{
"@type": "Question",
"name": "Comment l'essaimage affecte-t-il la fonction organique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut altérer la fonction des organes touchés, entraînant divers symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes généraux associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, fièvre et perte d'appétit sont des symptômes généraux fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cancer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de cancer et de l'organe affecté."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'essaimage tumoral ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le dépistage précoce et le traitement des cancers primaires."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à réduire le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et l'exercice, est bénéfique."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'essaimage ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de plusieurs cancers et leur essaimage."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce des cancers peut réduire le risque d'essaimage."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'essaimage tumoral ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chimiothérapie, la radiothérapie et la chirurgie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle efficace contre l'essaimage ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être efficace pour retirer les métastases si elles sont localisées."
}
},
{
"@type": "Question",
"name": "Comment la chimiothérapie aide-t-elle ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie cible les cellules cancéreuses, réduisant la taille des tumeurs."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée pour l'essaimage ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut cibler les métastases et soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés pour l'essaimage ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés existent, visant des mutations spécifiques des cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'essaimage ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la douleur, l'insuffisance organique et les infections."
}
},
{
"@type": "Question",
"name": "L'essaimage peut-il entraîner des métastases multiples ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'essaimage peut provoquer des métastases dans plusieurs organes simultanément."
}
},
{
"@type": "Question",
"name": "Comment l'essaimage affecte-t-il la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut réduire la qualité de vie en provoquant des douleurs et des limitations fonctionnelles."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru d'infections ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements et l'essaimage peuvent affaiblir le système immunitaire."
}
},
{
"@type": "Question",
"name": "L'essaimage peut-il causer des problèmes respiratoires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si les poumons sont touchés, cela peut entraîner des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'essaimage ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le type de cancer, le stade avancé et l'âge du patient."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans l'essaimage ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque d'essaimage."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'essaimage ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'alimentation peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "Les infections chroniques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections chroniques peuvent augmenter le risque de développer des cancers."
}
},
{
"@type": "Question",
"name": "L'exposition à des substances toxiques est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances cancérigènes peut augmenter le risque d'essaimage."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University of Cologne, Cologne, Germany.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany. hm.kvasnicka@patho-uwh.de.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University Medical Center Mainz, JGU-Mainz, Mainz 55131, Germany.
Joint Unit Immunopathology, Institute of Pathology, University Medical Center, JGU-Mainz and TRON, Translational Oncology at the University Medical Center, JGU-Mainz, Mainz 55131, Germany.
Institute of Pathology, Heidelberg University Hospital, Heidelberg 69120, Germany.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, University of Arizona, College of Medicine, Phoenix, AZ, United States.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Haematology, Queen's University, Belfast, United Kingdom.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Eskisehir City Hospital, Eskisehir, Turkey.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan; Department of Diagnostic Pathology, Fukui Prefecture Hospital, Fukui, Japan. Electronic address: nakanumayasu@gmail.com.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Fukui Prefecture Hospital, Fukui, Japan.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Fukui Prefecture Hospital, Fukui, Japan.
Publications dans "Essaimage tumoral" :
2 publications dans cette catégorie
Affiliations :
Department of Digestive Surgery, Fukui Prefecture Hospital, Fukui, Japan.
Publications dans "Essaimage tumoral" :
To evaluate the efficacy and toxicity of intravitreal carboplatin plus melphalan for the treatment of vitreous seeds in eyes with retinoblastoma (RB)....
This retrospective series at a tertiary referral center included 22 consecutive RB patients who had received intravitreal carboplatin (16 μg per 0.05 ml) combined with melphalan (30 μg in 0.03 ml) [IV...
There were 22 eyes of 22 patients, divided into primary group (n = 13) without history of previous intravitreal chemotherapy (IViC) and refractory group (n = 9) with history of previous IViC using mel...
Based on this interventional case series for primary and refractory vitreous RB seeds, carboplatin plus melphalan therapy may be effective with few toxic side effects....
As a result of advances in the treatment of lung cancer, the life expectancy of lung cancer patients has improved significantly, but it remains the leading cause of cancer death worldwide. For decades...
Recently, there has been an increase in the number of reports of needle tract seeding (NTS) of tumor cells after a biopsy as one of the adverse events related to endoscopic ultrasonography-guided fine...
A 70-year-old woman with a diagnosis of pancreatic head-body-tail cancer presented to our department for surgery. Transgastric EUS-FNA and biopsy established the histological diagnosis in her case. We...
In pancreatic head cancer cases, the puncture route is often included in the resection area of radical surgery, and NTS is seldom considered as a potential clinical problem. However, NTS can progress ...
Aqueous humor from eyes with active retinoblastoma contains tumor-derived cell-free DNA....
Single retrospective case report....
A 13-year-old girl with acute right eye pain and redness was diagnosed with hypertensive anterior uveitis. Following initial management, she was referred to ocular oncology for an atypical clinical pi...
RB1 sequencing analysis of tumor-derived cell-free DNA from aqueous humor can confirm the diagnosis of retinoblastoma in cases of diagnostic uncertainty....
Co-occurrence of myelodysplastic syndrome (MDS) and plasma cell neoplasm in patients with no history of chemo and/or radiotherapy is rarely reported. Herein, we report a case of a female in her sevent...
Sebaceous neoplasms describe a group of tumors with sebaceous differentiation commonly seen in lesions located primarily in the face and neck. The majority of these lesions are benign, while malignant...
Neuroendocrine neoplasms (NENs), also known as neuroendocrine tumors (NETs), are rare tumors derived from cells with characteristics of both nerve and endocrine cells. The clinical presentation, diagn...
Radon is a carcinogenic factor, but the effects of the potential carcinogenicity of radon progeny on the human body during the prenatal period have not yet been explored. Based on data regarding the h...
The present study aimed to compare the computed tomography (CT) and magnetic resonance imaging (MRI) features of solid pseudopapillary neoplasms (SPNs) and pancreatic neuroendocrine neoplasms (pNENs)....
Lesion imaging features of 39 patients with SPNs and 127 patients with pNENs were retrospectively extracted from 104 CT and 91 MRI scans....
Compared to pNEN patients, SPN patients were significantly younger (mean age 51.8 yrs versus 32.7 yrs) and more often female (female: male ratio, 5.50:1 versus 1.19:1). Most SPNs and pNENs presented a...
The present study provides three key features for differentiating SPNs from pNENs extracted from a large patient cohort: presence of a capsule, absence of arterial hyperenhancement, and low patient ag...
The recently published International Consensus Classification (ICC) of myeloid neoplasms summarized the results of an in-depth effort by pathologists, oncologists, and geneticists aimed to update the ...